4.7 Article

Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene

Journal

BLOOD
Volume 115, Issue 6, Pages 1264-1266

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2009-07-233965

Keywords

-

Categories

Funding

  1. Canadian Institutes of Health Research [MOP 97942]
  2. Heart and Stroke Foundation of Ontario [T5888]
  3. Career Investigator Award
  4. Bayer Canada
  5. Ontario Graduate Student Scholarship
  6. Canada Research Chairs in Molecular Hemostasis (C.P.M.H.)
  7. Genetics of Complex Diseases

Ask authors/readers for more resources

Quebec platelet disorder (QPD) is an autosomal dominant bleeding disorder linked to a region on chromosome 10 that includes PLAU, the urokinase plasminogen activator gene. QPD increases urokinase plasminogen activator mRNA levels, particularly during megakaryocyte differentiation, without altering expression of flanking genes. Because PLAU sequence changes were excluded as the cause of this bleeding disorder, we investigated whether the QPD mutation involved PLAU copy number variation. All 38 subjects with QPD had a direct tandem duplication of a 78-kb genomic segment that includes PLAU. This mutation was specific to QPD as it was not present in any unaffected family members (n = 114), unrelated a French Canadians (n = 221), or other persons tested (n = 90). This new information on the genetic mutation will facilitate diagnostic testing for QPD and studies of its pathogenesis and prevalence. QPD is the first bleeding disorder to be associated with a gene duplication event and a PLAU mutation. (Blood. 2010;115:1264-1266)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available